Comparing trajectories for PTEN-cancer cells for monotherapy (Fig. 2C) with these for combination therapy (Fig. 4C) we may notice that Mdm2 inhibitor administration leads to an increase of p53killer oscillation amplitude. This evidence concerns the gene PTEN and cancer.